Abstract
Myocardial infarction leads to loss of tissue and impairment of cardiac performance. The remaining myocytes are unable to reconstitute the necrotic tissue, and the post-infarcted heart deteriorates with time1. Injury to a target organ is sensed by distant stem cells, which migrate to the site of damage and undergo alternate stem cell differentiation2,3,4,5; these events promote structural and functional repair6,7,8. This high degree of stem cell plasticity prompted us to test whether dead myocardium could be restored by transplanting bone marrow cells in infarcted mice. We sorted lineage-negative (Lin-) bone marrow cells from transgenic mice expressing enhanced green fluorescent protein9 by fluorescence-activated cell sorting on the basis of c-kit expression10. Shortly after coronary ligation, Lin- c-kit POS cells were injected in the contracting wall bordering the infarct. Here we report that newly formed myocardium occupied 68% of the infarcted portion of the ventricle 9?days after transplanting the bone marrow cells. The developing tissue comprised proliferating myocytes and vascular structures. Our studies indicate that locally delivered bone marrow cells can generate de novo myocardium, ameliorating the outcome of coronary artery disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1038%2F35070587/MediaObjects/41586_2001_Article_BF35070587_Fig1_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1038%2F35070587/MediaObjects/41586_2001_Article_BF35070587_Fig2_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1038%2F35070587/MediaObjects/41586_2001_Article_BF35070587_Fig3_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1038%2F35070587/MediaObjects/41586_2001_Article_BF35070587_Fig4_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1038%2F35070587/MediaObjects/41586_2001_Article_BF35070587_Fig5_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1038%2F35070587/MediaObjects/41586_2001_Article_BF35070587_Fig6_HTML.jpg)
Similar content being viewed by others
References
Pfeffer, M. A. & Braunwald, E. Ventricular remodeling after myocardial infarction. Circulation81, 1161–1172 (1990).
Ferrari, G. et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science279, 1528–1530 (1998).
Jackson, K. A., Mi, T. & Goodell, M. A. Hematopoietic potential of stem cells isolated from murine skeletal muscle. Proc. Natl Acad. Sci. USA96, 14482–14486 (1999).
Eglitis, M. A. & Mezey, E. Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. Proc. Natl Acad. Sci. USA94, 4080–4085 (1997).
Theise, N. D. et al. Liver from bone marrow in humans. Hepatology32, 11–16 (2000).
Brazelton, T. A., Rossi, F. M. V., Keshet, G. I. & Blau, H. M. From marrow to brain: expression of neuronal phenotypes in adult mice. Science290, 1775–1779 (2000).
Mezey, E., Chandross, K. J., Harta, G., Maki, R. A. & McKercher, S. R. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science290, 1779–1782 (2000).
Vogel, G. Stem cells: new excitements, persistent questions. Science290, 1672–1674 (2000).
Hadjantonakis, A. K., Gerstenstein, M., Ikawa, M., Okabe, M. & Nagy, A. Generating green fluorescent mice by germline transmission of green fluorescent ES cells. Mech. Dev.76, 79–90 (1998).
Orlic, D., Fischer, R., Nishikawa, S.-I., Nienhuis, A. W. & Bodine, D. M. Purification and characterization of heterogeneous pluripotent hematopoietic stem cell populations expressing high levels of c-kit receptor. Blood82, 762–770 (1993).
Li, Q. et al. Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J. Clin. Invest.100, 1991–1999 (1997).
Durocher, D., Charron, F., Warren, R., Schwartz, R. J. & Nemer, M. The cardiac transciption factors Nkx2-5 and GATA-4 are mutual cofactors. EMBO J.16, 5687–5696 (1997).
Morin, S., Charron, F., Robitaille, L. & Nemer, M. GATA-dependent recruitment of MEF2 proteins to target promoters. EMBO J.19, 2046–2055 (2000).
Beardsle, M. A., Laing, J. G., Beyer, E. C. & Saffitz, J. E. Rapid turnover of connexin43 in the adult rat heart. Circ. Res.83, 629–635 (1998).
Musil, L. S., Le, A. N., VanSlyke, J. K. & Roberts, L. M. Regulation of connexin degradation as a mechanism to increase gap junction assembly and function. J. Biol. Chem.275, 25207–25215 (2000).
Scholzen, T. & Gerdes, J. The ki-67 protein: from the known and the unknown. J. Cell. Physiol.182, 311–322 (2000).
Kajstura, J. et al. Myocyte cellular hyperplasia and myocyte cellular hypertrophy contribute to chronic ventricular remodeling in coronary artery narrowing-induced cardiomyopathy in rats. Circ. Res.74, 383–400 (1994).
Clarke, D. L. Generalized potential of adult neural stem cells. Science288, 1660–1663 (2000).
Theise, N. D. et al. Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation. Hepatology31, 235–240 (2000).
Lagasse, E. et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo.Nature Med.6, 1229–1234 (2000).
Kunisada, T. et al. Transgene expression of steel factor in the basal layer of epidermis promotes survival, proliferation, differentiation and migration of melanocyte precursors. Development125, 2915–2923 (1998).
Matsui, Y., Zsebo, K. M. & Hogan, B. Embryonic expression of a haematopoietic growth factor encoded by the S1 locus and the ligand for c-kit. Nature347, 667–669 (1990).
Morrison, S. J., Uchida, N. & Weissman, I. L. The biology of hematopoietic stem cells. Annu. Rev. Cell Dev. Biol.11, 35–71 (1994).
Morrison, S. J., Shah, N. M. & Anderson, D. J. Regulatory mechanisms in stem cell biology. Cell88, 287–298 (1997).
Tomita, S. et al. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation100 (Suppl.), II-247–II-256 (1999).
Li, B. et al. Insulin-like growth factor-1 attenuates the detrimental impact of non occlusive coronary artery constriction on the heart. Circ. Res.84, 1007–1019 (1999).
Leri, A. et al. Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell. J. Clin. Invest.101, 1326–1342 (1998).
Kajstura, J. et al. Myocyte proliferation in end-stage cardiac failure in humans. Proc. Natl Acad. Sci. USA95, 8801–8805 (1998).
Kajstura, J. et al. Telomere shortening is an in vivo marker of myocyte replication and aging. Am. J. Pathol.156, 813–819 (2000).
Leri, A. et al. Pacing-induced heart failure in dogs enhances the expression of p53 and p53-dependent genes in ventricular myocytes. Circulation97, 194–203 (1998).
Acknowledgements
We thank Dr S. Izumo for providing us with the Csx2.5 antibody. This work was supported by grants from the NIH. S.C. is supported by a fellowship from the Mario Negri Institute of Pharmacologic Research, Milan, Italy.
Author information
Authors and Affiliations
Corresponding author
Supplementary information
FACS of mouse bone marrow: Lin- bone marrow cells from EGFP transgenic mice sorted by FACS based on c-kit expression. The fraction of c-kit POS cells (upper gate) was 6.4%: c-kit NEG cells are shown in the lower gate. c-kit POS cells were 1-2 logs brighter than c-kit NEG cells.
EGFP Localization: MI injected with Lin- c-kitPOS cells. Border zone; viable myocardium (VM) and new band (NB) of myocardium separated by an area of infarcted non-repairing tissue (arrows). A: EGFP (green); B: Cardiac myosin (red); C: Combination of EGFP and myosin (red- green); PI-stained nuclei (blue). A-C, X280.
Y Chromosome Localization:A-C: MI injected with Lin- c-kitPOS cells; regenerating myocardium (arrowheads). A: Cardiac myosin (red); B: Y chromosome (green); C: Combination of Y chromosome (light blue) and PI-labeled nuclei (dark blue). Lack of Y chromosome in infarcted tissue (IT) in subendocardium and spared myocytes (SM) in subepicardium. A-C, X400.
EGFP Localization in the Myocardium: Regenerating myocardium in MI injected with Lin- c- kitPOS cells. A,D: EGFP (green); B: Cardiac myosin (red); E: _-smooth muscle actin in arterioles (red); C: Combination of EGFP and myosin staining (yellow); F: Combination of EGFP and _- smooth muscle actin (yellow-red); C,F: PI-stained nuclei (blue). A-F, X650.
Expression of GATA-4: GATA-4 in cardiac myosin positive cells. A: PI-stained nuclei (blue); B: GATA-4 labeling (green); C: Cardiac myosin (red); combination of GATA-4 with PI (bright fluorescence in nuclei). A-C, X650.
BrdU and Ki67 Labeling: A-F: Regenerating myocardium in MI injected with Lin- c-kitPOS cells. A-C: BrdU; D-F: Ki67. A,D: PI-labeled nuclei (blue); B,E: BrdU- and Ki67-labeled nuclei (green); C: _-sarcomeric actin (red); F: _-smooth muscle actin (red). Bright fluorescence: combination of PI with BrdU (C) or Ki67 (F). A-C, X900; D-F, X500.
Lin- c-kitPOS Cell in the Infarcted Myocardium. MI injected with Lin- c-kitPOS cells. Undifferentiated small cell; A: c-kit labeling on the cell surface (green); B: EGFP (red); C: c-kit and EGFP (yellow-green-red). PI-labeled nuclei (blue). EGFP negative cells (nuclei) outside the regenerating myocardium. A-C, X1,500.
![](http://media.springernature.com/full/springer-static/esm/art%3A10.1038%2F35070587/MediaObjects/41586_2001_BF35070587_MOESM1_ESM.gif)
![](http://media.springernature.com/full/springer-static/esm/art%3A10.1038%2F35070587/MediaObjects/41586_2001_BF35070587_MOESM2_ESM.jpg)
![](http://media.springernature.com/full/springer-static/esm/art%3A10.1038%2F35070587/MediaObjects/41586_2001_BF35070587_MOESM3_ESM.jpg)
![](http://media.springernature.com/full/springer-static/esm/art%3A10.1038%2F35070587/MediaObjects/41586_2001_BF35070587_MOESM4_ESM.jpg)
![](http://media.springernature.com/full/springer-static/esm/art%3A10.1038%2F35070587/MediaObjects/41586_2001_BF35070587_MOESM5_ESM.jpg)
![](http://media.springernature.com/full/springer-static/esm/art%3A10.1038%2F35070587/MediaObjects/41586_2001_BF35070587_MOESM6_ESM.jpg)
![](http://media.springernature.com/full/springer-static/esm/art%3A10.1038%2F35070587/MediaObjects/41586_2001_BF35070587_MOESM7_ESM.jpg)
Rights and permissions
About this article
Cite this article
Orlic, D., Kajstura, J., Chimenti, S. et al. Bone marrow cells regenerate infarcted myocardium. Nature 410, 701–705 (2001). https://doi.org/10.1038/35070587
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/35070587
This article is cited by
-
Regeneration of the heart: from molecular mechanisms to clinical therapeutics
Military Medical Research (2023)
-
Effect of once versus twice intracoronary injection of allogeneic-derived mesenchymal stromal cells after acute myocardial infarction: BOOSTER-TAHA7 randomized clinical trial
Stem Cell Research & Therapy (2023)
-
Current Status of Stem Cell Therapy in Heart Failure
Indian Journal of Surgery (2023)
-
Stem cell-based therapies for heart failure management: a narrative review of current evidence and future perspectives
Heart Failure Reviews (2023)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.